Roche Holding AG
- Country
- ๐จ๐ญSwitzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
- Introduction
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 3000
- Registration Number
- NCT00002334
- Locations
- ๐บ๐ธ
N Texas Ctr for AIDS & Clin Rsch, Dallas, Texas, United States
๐บ๐ธCook County Hosp, Chicago, Illinois, United States
๐บ๐ธRespiratory Associates, Corpus Christi, Texas, United States
An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 600
- Registration Number
- NCT00002118
- Locations
- ๐บ๐ธ
Hoffmann - La Roche Inc, Nutley, New Jersey, United States
An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT00002265
- Locations
- ๐บ๐ธ
Dr Robert Swartz, Fort Myers, Florida, United States
๐บ๐ธAIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
๐บ๐ธMed Service, Miami, Florida, United States
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2016-02-15
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 52
- Registration Number
- NCT00022763
- Locations
- ๐บ๐ธ
Children's Hosp Los Angeles, Los Angeles, California, United States
๐บ๐ธNew York Hosp - Cornell / Program for Children with AIDS, New York, New York, United States
๐บ๐ธBronx Lebanon Hosp Ctr, Bronx, New York, United States